Evidence map›Paper›PMID 34294715›Full record

ArticleNature communications2021

Author Correction: The T cell receptor repertoire of tumor infiltrating T cells is predictive and prognostic for cancer survival.

Sara Valpione, Piyushkumar A Mundra, Elena Galvani, Luca G Campana, Paul Lorigan, Francesco De Rosa, Avinash Gupta, John Weightman, Sarah Mills, Nathalie Dhomen and 1 more

Abstract readPublished Erratum
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Trial
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Sara ValpioneMolecular Oncology Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Macclesfield, Cheshire, UK.
Piyushkumar A MundraMolecular Oncology Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Macclesfield, Cheshire, UK.
Elena GalvaniMolecular Oncology Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Macclesfield, Cheshire, UK.
Luca G CampanaDepartment of Surgery, The Christie NHS Foundation Trust, previously Department of Surgical Oncological and Gastroenterological Sciences DISCOG (University of Padova), The Christie NHS Foundation Trust, Manchester, UK.ORCID http://orcid.org/0000-0002-8466-8459
Paul LoriganMedical Oncology, The Christie NHS Foundation Trust, Manchester, UK.ORCID http://orcid.org/0000-0002-8875-2164
Francesco De RosaImmunotherapy - Cell Therapy and Biobank, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) "Dino Amadori" IRCCS, Meldola, Italy.ORCID http://orcid.org/0000-0003-0511-1298
Avinash GuptaMedical Oncology, The Christie NHS Foundation Trust, Manchester, UK.
John WeightmanMolecular Biology Core Facility, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Macclesfield, Cheshire, UK.
Sarah MillsManchester Cancer Research Centre Biobank, The Christie NHS Foundation Trust, Manchester, UK.
Nathalie DhomenMolecular Oncology Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Macclesfield, Cheshire, UK.
Richard MaraisMolecular Oncology Group, Cancer Research UK Manchester Institute, The University of Manchester, Alderley Park, Macclesfield, Cheshire, UK. richard.marais@cruk.manchester.ac.uk.ORCID http://orcid.org/0000-0001-7484-4183

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34294715
PMCPMC8298617

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.